5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pulmonary vascular remodeling is a pathophysiological feature that common to all classes of pulmonary hypertension (PH) and right ventricular dysfunction, which is the major prognosis-limiting factor. Vascular, as well as cardiac tissue remodeling are associated with a re-expression of fetal variants of cellular adhesion proteins, including tenascin-C (Tn-C). We analyzed circulating levels of the fetal Tn-C splicing variants B + and C + Tn-C in serum of PH patients to evaluate their potential as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction. Serum concentrations of B + and C + Tn-C were determined in 80 PH patients and were compared to 40 healthy controls by enzyme-linked immunosorbent assay. Clinical, laboratory, echocardiographic, and functional data were correlated with Tn-C levels. Serum concentrations of both Tn-C variants were significantly elevated in patients with PH ( p < 0.05). Significant correlations could be observed between Tn-C and echocardiographic parameters, including systolic pulmonary artery pressure (B + Tn-C: r = 0.31, p < 0.001, C + Tn-C: r = 0.26, p = 0.006) and right atrial area (B + Tn-C: r = 0.46, p < 0.001, C + Tn-C: r = 0.49, p < 0.001), and laboratory values like BNP (B + Tn-C: r = 0.45, p < 0.001, C + Tn-C: r = 0.42, p < 0.001). An inverse correlation was observed between Tn-C variants and 6-minute walk distance as a functional parameter (B + Tn-C: r = −0.54, p < 0.001, C + Tn-C: r = −0.43, p < 0.001). In a multivariate analysis, B + Tn-C, but not C + Tn-C, was found to be an independent predictor of pulmonary hypertension. Both fetal Tn-C variants may represent novel biomarkers that are capable of estimating both pulmonary vascular remodeling and right ventricular load. The potential beneficial impact of Tn-C variants for risk stratification in patients with PH needs further investigation.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.

          The Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL Registry) was established to characterize the clinical course, treatment, and predictors of outcomes in patients with pulmonary arterial hypertension (PAH) in the United States. To date, estimated survival based on time of patient enrollment has been established and reported. To determine whether the survival of patients with PAH has improved over recent decades, we assessed survival from time of diagnosis for the REVEAL Registry cohort and compared these results to the estimated survival using the National Institutes of Health (NIH) prognostic equation. Newly or previously diagnosed patients (aged ≥ 3 months at diagnosis) with PAH enrolled from March 2006 to December 2009 at 55 US centers were included in the current analysis. A total of 2,635 patients qualified for this analysis. One-, 3-, 5-, and 7-year survival rates from time of diagnostic right-sided heart catheterization were 85%, 68%, 57%, and 49%, respectively. For patients with idiopathic/familial PAH, survival rates were 91% ± 2%, 74% ± 2%, 65% ± 3%, and 59% ± 3% compared with estimated survival rates of 68%, 47%, 36%, and 32%, respectively, using the NIH equation. Comprehensive analysis of survival from time of diagnosis in a large cohort of patients with PAH suggests considerable improvements in survival in the past 2 decades since the establishment of the NIH registry, the effects of which most likely reflect a combination of changes in treatments, improved patient support strategies, and possibly a PAH population at variance with other cohorts
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Advances in tenascin-C biology

            Tenascin-C is an extracellular matrix glycoprotein that is specifically and transiently expressed upon tissue injury. Upon tissue damage, tenascin-C plays a multitude of different roles that mediate both inflammatory and fibrotic processes to enable effective tissue repair. In the last decade, emerging evidence has demonstrated a vital role for tenascin-C in cardiac and arterial injury, tumor angiogenesis and metastasis, as well as in modulating stem cell behavior. Here we highlight the molecular mechanisms by which tenascin-C mediates these effects and discuss the implications of mis-regulated tenascin-C expression in driving disease pathology.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tenascin-C in development and disease: gene regulation and cell function.

              Tenascin-C (TN-C) is a modular and multifunctional extracellular matrix (ECM) glycoprotein that is exquisitely regulated during embryonic development and in adult tissue remodeling. TN-C gene transcription is controlled by intracellular signals that are generated by multiple soluble factors, integrins and mechanical forces. These external cues are interpreted by particular DNA control elements that interact with different classes of transcription factors to activate or repress TN-C expression in a cell type- and differentiation-dependent fashion. Among the transcriptional regulators of the TN-C gene that have been identified, the homeobox family of proteins has emerged as a major player. Downstream from TN-C, intracellular signals that are relayed via specific cell surface receptors often impart contrary cellular functions, even within the same cell type. A key to understanding this behavior may lie in the dual ability of TN-C-enriched extracellular matrices to generate intracellular signals, and to define unique cellular morphologies that modulate these signal transduction pathways. Thus, despite the contention that TN-C null mice appear to develop and act normally, TN-C biology continues to provide a wealth of information regarding the complex nature of the ECM in development and disease.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                08 November 2017
                November 2017
                : 18
                : 11
                : 2371
                Affiliations
                [1 ]Department of Internal Medicine I, Division of Cardiology, Angiology, Pneumology and Intensive Medical Care, Jena University Hospital, Friedrich-Schiller-University, 07747 Jena, Germany; Ilonka.Rohm@ 123456med.uni-jena.de (I.R.); Katja.Gruen@ 123456med.uni-jena.de (K.G.); Linda.Mueller@ 123456med.uni-jena.de (L.M.M.); DANIEL.KRETZSCHMAR@ 123456med.uni-jena.de (D.K.); Michael.Fritzenwanger@ 123456med.uni-jena.de (M.F.); Christian.Schulze@ 123456med.uni-jena.de (P.C.S.)
                [2 ]Department of Internal Medicine II, Division of Cardiology, Elisabeth Klinikum Schmalkalden, 98574 Schmalkalden, Germany; Atilla.Yilmaz@ 123456elisabeth-klinikum.de
                [3 ]Department of Cardiology, Charité–Universitätsmedizin Berlin, 12203 Berlin, Germany; Alexander.Lauten@ 123456charite.de
                [4 ]Department of Internal Medicine, Division of Cardiology, University Hospital Düsseldorf, Heinrich Heine University, 40225 Düsseldorf, Germany; christian.jung@ 123456med.uni-duesseldorf.de
                [5 ]Institute of Pathology, Jena University Hospital, Friedrich-Schiller-University, 07743 Jena, Germany; Alexander.Berndt@ 123456med.uni-jena.de
                Author notes
                [* ]Correspondence: Marcus.Franz@ 123456med.uni-jena.de ; Tel.: +49-(0)-3641-9324127; Fax: +49-(0)-3641-9324102
                Author information
                https://orcid.org/0000-0001-6543-4684
                Article
                ijms-18-02371
                10.3390/ijms18112371
                5713340
                29117120
                40ad4ddf-b42a-489d-b3f8-2d4b33ccb65e
                © 2017 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 08 October 2017
                : 04 November 2017
                Categories
                Article

                Molecular biology
                fetal tenascin-c,pulmonary hypertension,vascular remodeling,right ventricular dysfunction

                Comments

                Comment on this article